These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 11379876)

  • 1. Mutation analysis of the origin recognition complex subunit 5 (ORC5L) gene in adult patients with myeloid leukemias exhibiting deletions of chromosome band 7q22.
    Fröhling S; Nakabayashi K; Scherer SW; Döhner H; Döhner K
    Hum Genet; 2001 Apr; 108(4):304-9. PubMed ID: 11379876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular cytogenetic delineation of deletions and translocations involving chromosome band 7q22 in myeloid leukemias.
    Fischer K; Fröhling S; Scherer SW; McAllister Brown J; Scholl C; Stilgenbauer S; Tsui LC; Lichter P; Döhner H
    Blood; 1997 Mar; 89(6):2036-41. PubMed ID: 9058725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ORC5L, a new member of the human origin recognition complex, is deleted in uterine leiomyomas and malignant myeloid diseases.
    Quintana DG; Thome KC; Hou ZH; Ligon AH; Morton CC; Dutta A
    J Biol Chem; 1998 Oct; 273(42):27137-45. PubMed ID: 9765232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation of human and fission yeast homologues of the budding yeast origin recognition complex subunit ORC5: human homologue (ORC5L) maps to 7q22.
    Ishiai M; Dean FB; Okumura K; Abe M; Moon KY; Amin AA; Kagotani K; Taguchi H; Murakami Y; Hanaoka F; O'Donnell M; Hurwitz J; Eki T
    Genomics; 1997 Dec; 46(2):294-8. PubMed ID: 9417919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic structure of the PIK3CG gene on chromosome band 7q22 and evaluation as a candidate myeloid tumor suppressor.
    Kratz CP; Emerling BM; Bonifas J; Wang W; Green ED; Le Beau MM; Shannon KM
    Blood; 2002 Jan; 99(1):372-4. PubMed ID: 11756194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloid malignancies with isolated 7q deletion can be further characterized by their accompanying molecular mutations.
    Hartmann L; Haferlach C; Meggendorfer M; Kern W; Haferlach T; Stengel A
    Genes Chromosomes Cancer; 2019 Oct; 58(10):698-704. PubMed ID: 30994218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CUX1 is a haploinsufficient tumor suppressor gene on chromosome 7 frequently inactivated in acute myeloid leukemia.
    McNerney ME; Brown CD; Wang X; Bartom ET; Karmakar S; Bandlamudi C; Yu S; Ko J; Sandall BP; Stricker T; Anastasi J; Grossman RL; Cunningham JM; Le Beau MM; White KP
    Blood; 2013 Feb; 121(6):975-83. PubMed ID: 23212519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytogenetic analysis of de novo acute myeloid leukemia with trilineage myelodysplasia in comparison with myelodysplastic syndrome evolving to acute myeloid leukemia.
    Tamura S; Takemoto Y; Hashimoto-Tamaoki T; Mimura K; Sugahara Y; Senoh J; Furuyama JI; Kakishita E
    Int J Oncol; 1998 Jun; 12(6):1259-62. PubMed ID: 9592183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MLL5, a homolog of Drosophila trithorax located within a segment of chromosome band 7q22 implicated in myeloid leukemia.
    Emerling BM; Bonifas J; Kratz CP; Donovan S; Taylor BR; Green ED; Le Beau MM; Shannon KM
    Oncogene; 2002 Jul; 21(31):4849-54. PubMed ID: 12101424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of chromosome engineering to model a segmental deletion of chromosome band 7q22 found in myeloid malignancies.
    Wong JC; Zhang Y; Lieuw KH; Tran MT; Forgo E; Weinfurtner K; Alzamora P; Kogan SC; Akagi K; Wolff L; Le Beau MM; Killeen N; Shannon K
    Blood; 2010 Jun; 115(22):4524-32. PubMed ID: 20233966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosome 5q deletion and epigenetic suppression of the gene encoding alpha-catenin (CTNNA1) in myeloid cell transformation.
    Liu TX; Becker MW; Jelinek J; Wu WS; Deng M; Mikhalkevich N; Hsu K; Bloomfield CD; Stone RM; DeAngelo DJ; Galinsky IA; Issa JP; Clarke MF; Look AT
    Nat Med; 2007 Jan; 13(1):78-83. PubMed ID: 17159988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Candidate gene isolation and comparative analysis of a commonly deleted segment of 7q22 implicated in myeloid malignancies.
    Kratz CP; Emerling BM; Donovan S; Laig-Webster M; Taylor BR; Thompson P; Jensen S; Banerjee A; Bonifas J; Makalowski W; Green ED; Le Beau MM; Shannon KM
    Genomics; 2001 Oct; 77(3):171-80. PubMed ID: 11597142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delineation of genomic regions in chromosome band 7q22 commonly deleted in myeloid leukemias.
    Fischer K; Brown J; Scherer SW; Schramm P; Stewart J; Fugazza G; Pascheberg U; Peter W; Tsui LC; Lichter P; Döhner H
    Recent Results Cancer Res; 1998; 144():46-52. PubMed ID: 9304706
    [No Abstract]   [Full Text] [Related]  

  • 14. Delineation of multiple deleted regions in 7q in myeloid disorders.
    Tosi S; Scherer SW; Giudici G; Czepulkowski B; Biondi A; Kearney L
    Genes Chromosomes Cancer; 1999 Aug; 25(4):384-92. PubMed ID: 10398433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural aberrations of chromosome 7 revealed by a combination of molecular cytogenetic techniques in myeloid malignancies.
    Brezinová J; Zemanová Z; Ransdorfová S; Pavlistová L; Babická L; Housková L; Melichercíková J; Sisková M; Cermák J; Michalová K
    Cancer Genet Cytogenet; 2007 Feb; 173(1):10-6. PubMed ID: 17284364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorescence in situ hybridization analysis of 110 hematopoietic disorders with chromosome 5 abnormalities: do de novo and therapy-related myelodysplastic syndrome-acute myeloid leukemia actually differ?
    Lessard M; Hélias C; Struski S; Perrusson N; Uettwiller F; Mozziconacci MJ; Lafage-Pochitaloff M; Dastugue N; Terré C; Brizard F; Cornillet-Lefebvre P; Mugneret F; Barin C; Herry A; Luquet I; Desangles F; Michaux L; Verellen-Dumoulin C; Perrot C; Van den Akker J; Lespinasse J; Eclache V; Berger R;
    Cancer Genet Cytogenet; 2007 Jul; 176(1):1-21. PubMed ID: 17574959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Significance of chromosome 7 abnormalities in myeloid malignancies].
    Shi WH; Li X; Chang CK
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Dec; 22(6):1739-43. PubMed ID: 25543507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional evidence from microcell-mediated chromosome transfer of myeloid leukemia suppressor genes on human chromosomes 7 and 11.
    Wilding J; Meijne E; Haines J; Moody J; Edwards A; Newbold RF; Parris C; Cox R; Silver A
    Genes Chromosomes Cancer; 2002 Aug; 34(4):390-7. PubMed ID: 12112528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myelodysplastic syndromes and acute myeloid leukemia with 17p deletion. An entity characterized by specific dysgranulopoïesis and a high incidence of P53 mutations.
    Lai JL; Preudhomme C; Zandecki M; Flactif M; Vanrumbeke M; Lepelley P; Wattel E; Fenaux P
    Leukemia; 1995 Mar; 9(3):370-81. PubMed ID: 7885035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New mechanisms of AML1 gene alteration in hematological malignancies.
    Roumier C; Fenaux P; Lafage M; Imbert M; Eclache V; Preudhomme C
    Leukemia; 2003 Jan; 17(1):9-16. PubMed ID: 12529654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.